Tristel plc ("Tristel" or "the Company") Issue of Equity

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that on 22 November 2016, 10,000 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") were issued and allotted pursuant to the exercise of share options.

Application has been made for the 10,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on 29 November 2016. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

The total number of Ordinary Shares in issue following Admission will be 42,377,917. Accordingly, the figure of 42,377,917 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

For further information please contact:

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303

finnCap

Tel: 020 7220 0500

Geoff Nash (Corporate Finance)

Giles Rolls (Corporate Finance)

Alice Lane (Corporate Broking)

Tristel plc published this content on 23 November 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 23 November 2016 14:32:03 UTC.

Original documenthttp://www.tristel.com/sites/default/files/tristel_issue_of_equity_221116.pdf

Public permalinkhttp://www.publicnow.com/view/B381202086BAD26B1FDC49A0082C9CFA123DB01B